Financial News
All News about Catalent Inc
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29020.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image29.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19588.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19488.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5155.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/707248/medical-professional-with-hand-on-head.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image48.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20466.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/12/eye-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/aapharma_13.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_2367.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_25822.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image38.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image-goodyear_tire__rubber_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image33.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9185.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221101005209/en/772236/5/Catalent_CMYK.jpg)
Catalent, Inc. Reports First Quarter Fiscal 2023 Results
November 01, 2022
From Catalent, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20338.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221017005902/en/772236/5/Catalent_CMYK.jpg)
Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast
October 17, 2022
From Catalent, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20213.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/shutterstock_1123885724.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2079.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/screenshot_2022-09-19_at_6.10.49_pm.png?width=1200&height=800&fit=crop)
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Catalent, Inc. to Present at September Investor Conferences
September 08, 2022
From Catalent, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/08/30/image-catalent.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.